PetMed ExpressPETS -1.02%56 Receivables Turnover is 24.70 as of Mar. 2026. GuruFocus rates PETS with a GF Score™ of 56/100 and a GF Value™ of $2.87 (Possible Value Trap). The stock has 4 warning signs investors should review. Among 655 Healthcare Providers & Services companies, PetMed Express ranks better than 96.18% on this metric.
The Receivables Turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by average Accounts Receivable. An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. PetMed Express's Revenue for the
three
months ended in Mar. 2026 was $42.8 Mil. PetMed Express's average Accounts Receivable for the
three
months ended in Mar. 2026 was $1.7 Mil.
Hence, PetMed Express's Receivables Turnover for the
three
months ended in Mar. 2026 was 24.70.
An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. This metric is commonly used to compare companies within the same industry to check whether they are on par with their competitors.
PetMed Express Receivables Turnover Related Terms
PetMed Express Receivables Turnover Historical Data
* Premium members only.
The historical data trend for PetMed Express's Receivables Turnover can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
PETS vs SHFH, BHIC, SCNX: Receivables Turnover Comparison
For the Pharmaceutical Retailers subindustry, PetMed Express's Receivables Turnover, along with its competitors' market caps and Receivables Turnover data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
PetMed Express Receivables Turnover vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, PetMed Express's Receivables Turnover distribution charts can be found below:
* The bar in red indicates where PetMed Express's Receivables Turnover falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
PetMed Express (PETS) has a Receivables Turnover of 24.70 as of Mar. 2026. The accounts receivables turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by Average Accounts Receivable. View historical data on PetMed Express and its competitors. According to the industry distribution chart, PetMed Express ranks #25 out of 655 companies in the Healthcare Providers & Services industry, placing it in the top 3.8%.
Is PetMed Express' Receivables Turnover too high?
PetMed Express' current Receivables Turnover is 24.70. The Healthcare Providers & Services industry median Receivables Turnover is 7.71. PetMed Express' value of 24.70 is 220.4% above this industry median. Based on the distribution chart, PetMed Express ranks #25 out of 655 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, PetMed Express has a GF Score™ of 56/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does PetMed Express' Receivables Turnover compare to SHFH and BHIC?
According to the Healthcare Providers & Services industry distribution chart, PetMed Express ranks #25 out of 655 companies for Receivables Turnover. This places PetMed Express in the top 4% of its industry — outperforming the majority of peers. The industry median Receivables Turnover is 7.71. PetMed Express' value of 24.70 is 220.4% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Receivables Turnover for a Healthcare Providers & Services company?
The median Receivables Turnover among Healthcare Providers & Services companies is 7.71, based on 655 companies in the industry. Companies in the top quartile (top 25%) have a Receivables Turnover significantly above this median, while those in the bottom quartile fall well below. However, Receivables Turnover should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. PetMed Express's current Receivables Turnover of 24.70 is 220.4% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Receivables Turnover mean?
A high Receivables Turnover can signal that a stock is expensive relative to its fundamentals. The accounts receivables turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by Average Accounts Receivable. View historical data on PetMed Express and its competitors. For the Healthcare Providers & Services industry, the median Receivables Turnover is 7.71 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. PetMed Express's current Receivables Turnover is 24.70. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PetMed Express stock overvalued right now?
Based on GuruFocus' analysis, PetMed Express (PETS) is currently considered Possible Value Trap. The stock's GF Value™ is $2.87, compared to a current price of $1.94 — trading 32.4% below its estimated fair value. The current Receivables Turnover is 24.70 and 220.4% above the Healthcare Providers & Services industry median of 7.71. PetMed Express' overall GF Score™ is 56/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Receivables Turnover calculated?
Receivables Turnover is calculated from a company's financial statements. For PetMed Express (PETS), the current Receivables Turnover is 24.70 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is PetMed Express (PETS) Overvalued in 2026?
Based on GuruFocus' analysis, PetMed Express stock appears to be undervalued.
The current stock price of $1.94 is trading 32.4% below its estimated GF Value™ of $2.87.
GuruFocus considers PetMed Express to be Possible Value Trap.
Key valuation signals for PETS:
Receivables Turnover: 24.70
GF Value™: $2.87 vs. price of $1.94 (32.4% below fair value)
Industry Position: 220.4% above the Healthcare Providers & Services median (#25 of 655)
No single metric tells the full story. See the PETS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
PetMed Express Inc is a nationwide direct-to-consumer pet pharmacy and online provider of prescription and non-prescription medications, foods, supplements, supplies, and vet services for dogs, cats, and horses. It markets and sells directly to consumers through its websites, toll-free numbers, and mobile application, offering convenience, price, speed of delivery, and customer service. It provides access to branded pharmaceuticals, generic medications, compounded prescription medications, over-the-counter health and wellness products, prescription and non-prescription food, pharmacy fulfillment, and AutoShip capabilities. Its digital platform offers pet healthcare solutions for chronic conditions, including allergies, arthritis, anxiety, kidney-related conditions, and hyperthyroidism.
56GF Score
Get the complete analysis for PETS
Receivables Turnover is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
PETS has been successfully added to your 
